Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference
Petros Pharmaceuticals, a leader in men's health therapeutics, announced that President Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference on March 9, 2022, at 2:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals, a leader in men's health therapeutics, announced that President Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference on March 9, 2022, at 2:00 PM ET. This virtual event will allow attendees to learn about the company’s initiatives in addressing men's health issues, including erectile dysfunction and Peyronie's disease. Boctor will also be available for one-on-one meetings throughout the conference. Interested parties can register for the summit online.
For more information, visit their registration page.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was -2.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.
Mr. Boctor will deliver his corporate presentation on Wednesday, March 9
at 2:00 PM ET.
Mr. Boctor will be available for one-on-one meetings throughout the conference.
Click here to register: Q1 Investor Summit - INVESTOR REGISTRATION
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
CONTACTS:
Jules Abraham
CORE IR
917-885-7378
pr@coreir.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.